Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
{{output}}
Introduction: About 20 patents have been published from 2013 to 2018 for developing advanced cancer therapeutics by targeting tubulin polymerization. Currently, there are several tubulin inhibitors that are in the drug development pipeline for various cancers ... ...